Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II chemoradiotherapy with oral satraplatin in renally impaired head and neck squamous cell carcinoma
jRCT2080221482Phase 2
- Sponsor
- Yakult Honsha
- Start
- Jun 2011
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of satraplatin in head and neck squamous cell carcinoma (HNSCC), sponsored by Yakult Honsha.
02
Drugs
satraplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on jRCT2080221482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221482.